1. P505 Real word long-term efficacy and safety of vedolizumab in managing ulcerative colitis versus crohn's disease: results from "long vedo" italian multicenter study. (30th January 2023) Authors: Mocci, G; Maconi, G; Onidi, F M; Cataletti, G; Elisei, W; Scaldaferri, F; Lorenzetti, R; Pagnini, C; Scarcelli, A; Graziani, M G; Di Paolo, M C; Pranzo, G; Luppino, I; Monterubbianesi, R; Faggiani, R; Ferronato, A; Savarino, E; Pica, R; Cocco, A; Rodino, S Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i635 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗